Information on COVID-19
Learn more about COVID-19, information about previously scheduled appointments and what you can do to help protect your child and family. View COVID-19 information.
Riley at IU Health Facilities have implemented visitor restrictions to help minimize the spread of COVID-19, flu and other respiratory viruses. View visitor restrictions.
Information on Previously Scheduled Outpatient Appointments
To ensure the health and safety of all our patients and team members during the coronavirus (COVID-19) pandemic, we’re making adjustments to some of our outpatient appointments. View updates to outpatient appointments.
Free Virtual Coronavirus Screenings
IU Health has launched a virtual clinic to offer individuals in Indiana regardless of age free coronavirus (COVID-19) screenings. View screening details.
Información sobre el COVID-19
Obtenga más información acerca del COVID-19, incluyendo las preguntas más frecuentes y lo que puede hacer para ayudar a protegerse y proteger a su familia. Ver información del COVID-19.
Restricciones para visitantes
Las instalaciones de salud de IU Health han implementado restricciones a los visitantes para ayudar a minimizar la propagación del COVID-19, la gripe y otros virus respiratorios. Ver restricciones para visitantes.
Información sobre citas ambulatorias previamente programadas
Para asegurar la salud y la seguridad de todos nuestros pacientes y empleados durante la pandemia del coronavirus (COVID-19), estamos haciendo ajustes en algunas de nuestras citas ambulatorias. Ver actualizaciones de citas ambulatorias.
Exámenes de coronavirus virtuales gratuitos
IU Health ha lanzado una clínica virtual para ofrecer a las personas en Indiana, independientemente de la edad, evaluaciones virtuales para la detección del coronavirus (COVID-19). Ver detalles de la evaluación.
The Precision Genomics program at Riley Hospital for Children at IU Health offers pediatric patients with aggressive and relapsed cancers an innovative approach at finding potential drug therapies aimed at benefiting each individual child’s unique case.
The first-of-its-kind program has identified therapeutic options in more than three quarters of the children evaluated. The most common cancers evaluated and treated to date in the program include solid tumors, brain cancers and leukemias.
Medical researchers have found that patient’s tumors are often driven by unique combinations of gene mutations. When it comes to treating cancer, knowing which mutations are in a tumor may be more important than where the tumor is found.
By analyzing the DNA, RNA and proteins of the cancer cells, as well as the DNA of the patient, our team is able to make real-time drug therapy recommendations for use in the child’s treatment plan in a matter of days.
This rapid turnaround time paired with targeted therapies can lead to better outcomes, reduced side effects and an overall improvement of quality of life.
The Precision Genomics program is a consultative service for genetic/genomic testing, working in collaboration with the treating physician to develop a personalized treatment plan based on the team’s pediatric-focused interpretation of the test results.
The program will facilitate testing, interpret testing, research therapeutic options, facilitate tumor board, and assist with drug approvals. In collaboration with the treating physician, the team will meet with the families to discuss genetic testing, as well as the interpretation of the results and recommendation.
The comprehensive care team includes medical director Dr. Jamie Renbarger, oncologists, pharmacists, molecular biologists, pathologists, social workers and genetic counselors. The team also works closely with other physicians, scientists and pediatric bioethicists at Riley at IU Health. The patient and their family are supported by a nurse coordinator who serves as their counselor through the process.
The treating physician is regularly updated and included throughout the process.
There’s no other program in the Midwest like the Precision Genomics program at Riley Children’s Health. By integrating patient care and research, this unparalleled program aims to improve outcomes in children with the most aggressive cancers while working to continually provide the best care for all children with cancer. We utilize the most sophisticated and comprehensive next-generation cancer diagnostic tests available today together with germline genomic sequencing to make the best treatment decisions for individual children with aggressive cancers.